Cancer Institute (NSW) Act 2003
12General functions of Cancer Institute
Start here
Get a plain-English read of 12
Turn the raw legal text into a practical explanation grounded in Cancer Institute (NSW) Act 2003.
12 General functions of Cancer Institute
12 General functions of Cancer Institute
(1) The Cancer Institute may do and perform all acts and things that are necessary or convenient for giving effect to its objectives.
(2) Without limiting subsection (1), the Cancer Institute has the following functions:
(a) to undertake, commission or sponsor cancer-related research and development,
(b) to facilitate collaboration and co-operation between bodies involved in cancer-related research and development and in doing so, to establish a publicly available register of such bodies,
(c) to provide a system that facilitates expeditious ethical approval for multi-centre clinical trials and other cancer-related research,
(d) to foster and support best practice in, and an evidence-based approach to, cancer control, including participating in the development, evaluation, recommendation or endorsement of guidelines, protocols and practices for cancer control,
(e) to accredit programs relating to cancer control, including prevention and screening programs,
(f) to review, monitor, evaluate and recommend improvements to cancer-related programs and proposed initiatives in the public health system in relation to cancer control,
(g) to facilitate improvements in the effectiveness of cancer control and to develop or endorse strategies to achieve such improvements,
(h) to review, develop or commission innovative programs for cancer control,
(i) to develop, in conjunction with the Ministry of Health and public health organisations, a State Cancer Plan by 30 June 2004 for consideration by the Minister for Health and, in conjunction with the Ministry of Health and public health organisations, to review and recommend changes (if any) to the Plan for consideration by the Minister for Health at least every 2 years after that date (or within such other period as may be determined by the Minister for Health),
(j) to advise and make recommendations to the Minister on the manner in which that portion of the money appropriated from the Consolidated Fund in any financial year to the Minister for Health, and which the Minister for Health has specifically designated to be administered by the Cancer Institute, is to be expended,